FrancophonIA/ELRC3.0 huggingface dataset:
English: IS
Maltese: A
English: These symptoms could include severe headache, numbness, weakness, paralysis, and impairment of coordination, vision, speech, language or memory..
Maltese: Dawn is-sintomi jistgħu jnkludu uġigħ ta' ras severa, tnemnim, debbulizza, paraliżi, u indeboliment fil-koordinazzjoni, vista, kliem, lingwa jew memorja.
English: Longstanding abuse of methylphenidate can lead to marked tolerance, psychological dependence, abnormal behaviour, psychotic episodes.
Maltese: L-abbuż kroniku ta' methylphenidate jista' jwassal għal tolleranza, dipendenza psikoloġika, imġiba anomala, episodji psikotiċi qawwija.
English: A risk to the suckling child cannot be excluded.
Maltese: Riskju għattarbija li qed terda' ma jistax jiġi eskluż.
English: Overall, cardiovascular events reported were mainly of cardiac arrhythmias (including tachycardia), hypertension, cardiac arrests, ischemia, QT prolongation, with some reports of sudden death.
Maltese: B'mod ġenerali, l-episodji kardjovaskulari rrapportati kienu b'mod prinċipali dawk ta' arritmiji kardijaċi (inkluż takikardija), pressjoni għolja, arresti kardijaċi, iskemija, prolongament tal-QT, b'xi rapporti ta' mewt f'daqqa.
English: MT - Malta Janssen-Cilag International N.V. Turnhoutseweg 30
Maltese: MT - Malta Janssen-Cilag International N.V.
English: - Medicines for depression, including amitriptyline, imipramine and fluoxetine, paroxetine - Medicines for epilepsy (anticonvulsants) (e.g. phenobarbital, phenytoin, primidone, etc) - medicines that thin the blood to prevent blood clots (blood thinners, e.g. warfarin) - dopaminergic drugs, including antipsychotics
Maltese: - Mediċini antiepilettiċi (mediċina kontra l-konvulżjonijiet) (eż. phenobarbital, fenitoina [phenytoin], primidone, eċċ.); mediċini li jraqqu d-demm biex jipprevjenu l-emboli (mediċini li jraqqu ddemm, eż. warfarina [warfarin]); - mediċini dopaminerġiċi, inklużi dawk antipsikotiċi.
English: Misuse and Cardiovascular Events
Maltese: Użu ħażin u Avvenimenti Kardjovaskulari
English: See section 4.3 for cerebrovascular conditions in which methylphenidate treatment in contraindicated.
Maltese: Ara sezzjoni 4.3 għall-kundizzjonijiet ċerebrovaskulari fejn kura b'methylphenidate hija kontraindikata.
English: Methylfenidaat HCl ratiopharm 10 mg 10 mg tablets
Maltese: Methylfenidaat HCl ratiopharm 10 mg 10 mg
English: Psychiatric disorders to monitor for are described below, and include (but are not limited to) motor or vocal tics, aggressive or hostile behaviour, agitation, anxiety, depression, psychosis, mania, delusions, irritability, lack of spontaneity, withdrawal and excessive perseveration.
Maltese: Disturbi psikjatriċi li għandhom jiġu segwiti huma deskritti isfel, u jinkludu (iżda mhux limitat għal) kontrazzjonijiet involontarji motorji u vokali, mġieba aggressiva jew ostili, aġitazzjoni, ansjetà, depressjoni, psikożi, manija, delużjonijiet, irritabilità, nuqqas ta' spontanjetà, għeluq fih/a innifsu/ha u perseveranza eċċessiva.
English: METHYLPHENIDATE RUBIO 20mg tablet
Maltese: METHYLPHENIDATE RUBIO 20mg
English: DK-Denmark Janssen-Cilag A/S Hammerbakken 19
Maltese: Janssen-Cilag A/S Hammerbakken 19 DK-3460
English: Psychiatric adverse events of particular interest with methylphenidate reported from clinical trials included aggression, violent behaviour, psychosis, mania, irritability and suicidality.
Maltese: L-episodji avversi psikjatriċi ta' interess partikolari rrappurtati b'methylphenidate minn provi kliniċi inkludew l-aggressjoni, l-imġiba vjolenti, il-psikożi, il-manija, l-irritabilità u s-suwiċidalità.
English: MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG; KUHLOWEG 37; ISERLOHN 58638; GERMANY
Maltese: KG; KUHLOWEG 37; ISERLOHN 58638; GERMANY
English: CONCERTA 54 mg retard tabletta
Maltese: Concerta 54 mg Retardtabletten
English: Forms of bipolar disorder
Maltese: Forom ta' disturb bipolari
English: 5220 Odense SØ Denmark
Maltese: Odense SØ
English: 18 mg 36 mg 54 mg
Maltese: 18 MG 36 MG 54
English: SE - Sweden UCB Nordic A/S Arne Jacobsens Allé 15
Maltese: SE - L-Iżvezja UCB Nordic A/S Arne Jacobsens Allé 15
English: CONCERTA 36 mg retard tabletta
Maltese: Concerta 36 mg Retardtabletten
English: Uncommon: diplopia, blurred vision, Rare: difficulties in visual accommodation, mydriasis, visual disturbance
Maltese: Mhux komuni: diplopija, vista sfukata, Rari: diffikultajiet fl-adattament viżiv, midrijażi, disturbi viżivi
English: CONCERTA 18 mg retard tabletta
Maltese: Concerta 18 mg Retardtabletten
English: 10 mg - tablet 20, 30, 40 mg - modifiedrelease capsule, hard
Maltese: 10 mg - pilloli 20, 30, 40 mg - kapsuli iebsa b'rilaxx modifikat
English: However, there are reports indicating that methylphenidate may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (e.g. phenobarbitol, phenytoin, primodone) and some antidepressants (tricyclics and selective serotonin reuptake inhibitors).
Maltese: Madankollu, hemm rapporti li jindikaw li methylphenidate jista' jinibixxi il-metaboliżmu ta' sustanzi kontra l-koagulazzjoni tad-demm coumarin, sustanzi kontra l-konvulżjonijiet (e.ż. phenobarbitol, phenytoin, primodone) u ta' xi antidepressanti (triċikliċi u inibituri selettivi tat-teħid mill-ġdid ta' serotonin).
English: 5 mg 10 mg 20 mg tablet
Maltese: 5 mg 10 mg 20 mg
English: CONCERTA 27 mg Retardtabletten 27. mg Prolonged-release tablet
Maltese: CONCERTA 27 mg Retardtabletten 27. mg
English: EQUASYM XL 30 MG CAPSULES
Maltese: XL 30 MG CAPSULES
English: There is a risk of sudden blood pressure increase during surgery.
Maltese: Hemm riskju ta' żjieda f'daqqa fil-pressjoni tad-demm waqt kirurġija.
English: The MAHs should evaluate newly identified or potential risks, or new new/important information on existing identified or potential risks, in the RMP on an ongoing basis
Maltese: Fl-RMP, il-MAHs għandhom jevalwaw riskji identifikati ġodda u potenzjali, jew informazzjoni ġdida/importanti dwar riskji identifikati jew potenzjali eżistenti fuq bażi kontinwa.
English: UCB Nordic A/S Arne Jacobsens Allé 15 2300 Köbenhavn S Denmark
Maltese: UCB Nordic A/S Arne Jacobsens Allé 15 2300
English: The safety evaluation of this procedure is mainly focussed on the following concerns potentially associated with methylphenidate treatment: cardiovascular risks, cerebrovascular risks, psychiatric disorders, carcinogenicity, effect on growth and effects of long term treatment.
Maltese: L-evalwazzjoni tas-sigurtà ta' din il-proċedura hi ffukata l-aktar fuq it-tħassib segwenti potenzjalment assoċjati mat-trattament b'methylphenidate: riskji kardjovaskulari, riskji ċerebrovaskulari, disturbi psikjatriċi, karċinoġeniċità, effett fuq it-tkabbir u effetti fuq it-trattament fit-tul.
English: Methylphenidate treatment does not need to be indefinite.
Maltese: It-trattament b'methylphenidate ma jeħtieġx li jkun wieħed indefinit.
English: Metabolism and nutritional disorders*
Maltese: Disturbi filmetaboliżmu u nnutrizzjoni*
English: METHYLPHENIDATE/RUBIO 5 MG/TAB 10 MG/TAB
Maltese: MG/TAB 10 MG/TAB
English: The recently published retrospective case control review of prescription records for more than 35,000 patients did not indicate either a moderate or a strong association between methylphenidate use and cancer risk in children for any of 18 defined cancer sites.
Maltese: Ir-reviżjoni retrospettiva ippubblikata reċentement tal-kontroll tal-każijiet ta' rekords ta' preskrizzjoni għal aktar minn 35,000 pazjent la indikat assoċjazzjoni moderata u lanqas qawwija bejn l-użu ta' methylphenidate u r-riskju tal-kanċer fit-tfal għal xi wieħed mit-18-il sit ta' kanċer definit.
English: LU
Maltese: Billi
English: EQUASYM XL 10 MG CAPSULES
Maltese: XL 10 MG CAPSULES
English: METHYLPHENIDATE RUBIO 5mg tablet
Maltese: METHYLPHENIDATE RUBIO 5mg
English: CONCERTA 54 mg Retardtabletten 54. mg Prolonged-release tablet
Maltese: CONCERTA 54 mg Retardtabletten 54. mg
English: CONCERTA 18 mg Retardtabletten 18. mg Prolonged-release tablet
Maltese: CONCERTA 18 mg Retardtabletten 18. mg
English: See section 4.3 for conditions in which methylphenidate treatment in contraindicated.
Maltese: Ara sezzjoni 4.3 għall-kundizzjonijiet fejn kura b'methylphenidate hija kontra-indikata.
English: A comprehensive history should document concomitant medications, past and present co-morbid medical and psychiatric disorders or symptoms, family history of sudden cardiac/unexplained death and accurate recording of pre-treatment height and weight on a growth chart (see sections 4.3 and 4.4)
Maltese: Storja komprensiva għandha tiddokumenta mediċini li qed jingħataw fl-istess waqt, disturbi jew sintomi mediċi u psikjatriċi ko-morbużi fil-passat jew attwali, storja tal-familja ta' mewt kardijaku/mhux spjegat f'daqqa, u dokumentazzjoni preċiża tattul u tal-piż qabel il-kura fuq tabella ta' l-iżvilupp (ara sezzjonijiet 4.3 u 4.4).
English: Cerebrovascular disorders
Maltese: Disturbi ċerebrovaskulari
English: Because a predominant action of methylphenidate is to increase extracelluar dopamine levels, methylphenidate may be associated with pharmacodynamic interactions when co-administered with direct and indirect dopamine agonists (including DOPA and tricyclic antidepressants) or with dopamine antagonists including antipsychotics.
Maltese: Peress li azzjoni predominanti ta' methylphenidate hija żjieda fil-livelli ekstraċellulari ta' dopamine, methylphenidate jista' jkun assoċjat ma' interazzjonijiet farmakodinamiċi meta jingħata flimkien ma' agonisti diretti jew indiretti ta' dopamine (inkluż DOPA u antidepressanti triċikliċi) jew ma' antagonisti ta' dopamine inkluż antipsikotiċi.
English: RO Romania
Maltese: RO Ir-Rumanija
English: 10 mg 20 mg 30 mg modified-release capsule, hard oral
Maltese: 10 mg 20 mg 30 mg kapsuli iebsa b'rilaxx modifikat użu orali
English: This included assessment on the impact of risks of cardiovascular, cerebrovascular and psychiatric disorders on the benefit/risk balance.
Maltese: Dan inkluda valutazzjoni fuq l-impatt tar-riskji ta' disturbi kardjovaskulari, ċerebrovaskulari u psikjatriċi fuq il-bilanċ tal-benefiċċju/riskju.
English: NOVARTIS FARMA S.P.A. Largo Umberto Boccioni 1 21040 VARESE
Maltese: Largo Umberto Boccioni 1
English: Uncommon: constipation
Maltese: Mhux komuni: dispnea
English: Common: anorexia, decreased appetite, moderately reduced weight and height gain during prolonged use in children*
Maltese: Komuni: anoressija, tnaqqis fl-aptit, tnaqqis moderat tal-piż u żieda fit-tul waqt l-użu prolongat fittfal*
English: Inducers or inhibitors of cytochrome P450 are not expected to have any relevant impact on methylphenidate pharmacokinetics.
Maltese: Indutturi jew inibituri ta' ċitokromju P450 mhux mistennija li jkollhom xi impatt rilevanti fuq ilfarmakokinetika ta' methylphenidate.
English: This product contains methylphenidate which may induce a false positive laboratory test for amphetamines, particularly with immunoassay screen test.
Maltese: Methylphenidate jista' jwassal għal testijiet tal-laboratorju pożittivi għal amphetamines foloz, speċjalment b'test ta' analiżi permezz ta' immunoassay.
English: The PI for all methylphenidate-containing products have warnings related to this point in section 4.4 of the SPC.
Maltese: Il-PI għall-prodotti kollha li fihom methylphenidate għandhom twissijiet relatati ma' dan il-punt f'sezzjoni 4.4 tal-SPC.
English: CONCERTA 36 mg Retardtabletten 36. mg Prolonged-release tablet
Maltese: CONCERTA 36 mg Retardtabletten 36. mg
English: Methylfenidaat HCl 10 mg tabletten 10 mg tablets
Maltese: Methylfenidaat HCl 10 mg tabletten 10 mg
English: Novartis Healthcare A/S, c/o Vistor hf., Hörgatún 2, 212 Garðabær, Iceland
Maltese: IS - L-Iżlanda Novartis Healthcare A/S, c/o Vistor hf., Hörgatún 2, 212 Garðabær, Iceland
English: Cases of neonatal cardiorespiratory toxicity, specifically fetal tachycardia and respiratory distress have been reported in spontaneous case reports.
Maltese: Każijiet ta' tossiċità kardjorespiratorja fit-trabi, speċifikatament takikardija fil-fetu u distress respiratorju kienu irrapportati f'rapporti ta' każijiet spontanji.
English: If paradoxical aggravation of symptoms or other serious adverse events occur, the dosage should be reduced or discontinued.
Maltese: Jekk iseħħ aggravar paradossali tas-sintomi jew ta' avvenimenti avversi serji oħra, id-dożaġġ għandu jitnaqqas jew jitwaqqaf.
English: METHYLPHENI TAD 5 mg Tabletten 5. mg
Maltese: METHYLPHENI TAD 5 mg Tabletten
English: Uncommon: dyspnoea
Maltese: Mhux komuni: stitikezza
English: DK - Denmark UCB Nordic A/S Arne Jacobsen Allé 15, DK-2300 Kobenhavn S Denmark
Maltese: UCB Nordic A/S Arne Jacobsen Allé 15, DK-2300
English: ITItaly
Maltese: IPPREŻENTATI
English: Very rare: convulsions, choreo-athetoid movements, reversible ischaemic neurological deficit Neuroleptic malignant syndrome (NMS; Reports were poorly documents and in most of cases, patients were also receiving other drugs, so the role of methylphenidate is unclear).
Maltese: Konvulżjonijiet, Movimenti korejoatetojdi, Nuqqas newroloġiku iskemiku riversibbli, Sindrome malinna newrolettika (NMS; Rapporti kienu dokumentati ħażin u fil-biċċa lkbira tal-każijiet, il-pazjenti kienu qed jirċievu wkoll mediċini oħra, għalhekk ir-rwol ta' methylphenidate mhux ċar).
English: Methylfenidaat HCl 10 mg PCH 10 mg tablets
Maltese: Methylfenidaat HCl 10 mg PCH 10 mg
English: Very rare: suicidal attempt (including completed suicide)*, transient depressed mood*, abnormal thinking, apathy, repetitive behaviours, over-focussing, Not known: delusions*, thought disturbances*, confusional state
Maltese: Rari ħafna: tentattivi ta' suwiċidju (inkluż suwiċidju mwettaq)*, burdata depressa temporanja*, ħsibijiet mhux normali, apatija, imġiba ripetittiva, iperfokalizzazzjoni, Mhux magħrufa: delirji*, disturbi fil-ħsibijiet*, stat konfużjonali
English: 18 MG 36 MG 54 MG
Maltese: 18mg 27mg 36 mg 54 mg
English: This scientific assessment on methylphenidate has reviewed the available safety data from clinical trials, preclinical studies, spontaneous reports and published literature.
Maltese: Din il-valutazzjoni xjentifika dwar methylphenidate għamlet reviżjoni tad-dejta dwar is-sigurtà disponibbli minn provi kliniċi, studji prekliniċi, rapporti spontanji u letteratura ippubblikata.
English: This medicinal product contains sucrose: patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency should not take this medicine
Maltese: Dan il-prodott mediċinali fih sucrose: pazjenti bi problemi ereditarji rari ta' intolleranza għal fructose, assorbiment ħażin ta' glucose-galactose jew insuffiċjenza ta' sucrose-isomaltase m'għandhomx jieħdu din il-mediċina.
English: Study on sexual maturation: a 2-year, long-term, open-label, prospective investigator initiated study in the US on 150 adolescents (12-17 years) with ADHD, to determine whether treatment with methylphenidate will prevent smoking in this population.
Maltese: Studju dwar il-maturazzjoni sesswali: studju prospettiv mibdi minn investigatur, b'tikketta mikxufa, b'terminu twil, ta' sentejn fl-Istati Uniti fuq 150 adoloxxent (12-17-il sena) b'ADHD, biex jiddetermina jekk it-trattament b'methylphenidate jevitax it-tipjip f'din il-popolazzjoni.
English: • pre-existing cerebrovascular disorders cerebral aneurysm, vascular abnormalities including vasculitis or stroke
Maltese: • Disturbi ċerebrovaskulari eżistenti minn qabel, anewriżma ċerebrali, anormalitajiet vaskulari inkluż vaskulite jew puplesija.
English: Very rare: Anaemia, leukopenia, thrombocytopenia, thrombocytopenic purpura Unknown: Pancytopenia
Maltese: Disturbi tad-demm u tas-sistema linfatika Rari ħafna: anemija, lewkopenija, tromboċitopenija, purpura tromboċitopenika
English: Medikinet 20 mg - retardierte Hartkapseln
Maltese: Medikinet 20 mg - retardierte Hartkapseln kapsuli iebsa b'rilaxx imtawwal
English: Not known: cerebrovascular disorders* (including vasculitis, cerebral haemorrhages, cerebrovascular accidents, cerebral arteritis, cerebral occlusion), grand mal convulsions*, migraine
Maltese: Disturbi ċerebrovasku lari* (inkluż vaskulite, emorraġiji ċerebrali, aċċidenti ċerebrovasku lari, arterite ċerebrali, okklużjoni ċerebrali), Konvulżjoniji et grand mal*,
English: Most cerebrovascular events from clinical trials were of migraine, with a higher incidence rate in methylphenidate-treated group compared with placebo group.
Maltese: Ħafna episodji ċerebrovaskulari minn provi kliniċi kienu emigranja, b'rata ta' inċidenza ogħla filgrupp trattat b'methylphenidate meta mqabbla mal-grupp tal-plaċebo.
English: Take special care with methylphenidate and tell a doctor if you or your child - Has been told to take these tablets for longer than 12 months (see section 3 below, on long-term use) - Is entering puberty (teenage years) - Is about to stop taking methylphenidate as your doctor may want to monitor your child for depression - has a heart disease or other serious heart problem - has had seizures (convulsions, epilepsy) or abnormal EEGs (electroencephalograms brain scans) - has high blood pressure.
Maltese: Oqgħod attent ħafna bil-methylphenidate u għaraf lit-tabib tiegħek jekk int jew it-tifel/tifla tiegħek - Ingħatajt struzzjoni biex tieħu dawn il-pilloli għal aktar minn 12-il xahar (ara s-sezzjoni 3 hawn taħt dwar l-użu fit-tul) - Dieħel/dieħla għall-pubertà (adolexxenza) - Wasalt biex tieqaf tieħu l-methylphenidate billi t-tabib tiegħek jista' jkun irid jimmonitorja littifel/tifla tiegħek għal depressjoni - għandek marda tal-qalb jew xi problema oħra serja tal-qalb - kellek attakki ta' puplesija (konvulsivi, epilettiċi) jew EEGs anomali (skens elettroenċefalogrammi tal-moħħ) - għandek pressjoni għolja tad-demm.
English: METHYLPHENIDATE RUBIO 10mg tablet
Maltese: METHYLPHENIDATE RUBIO 10mg
English: Some pre-clinical evidence was submitted suggesting that there is a differential effect of acute vs. chronic treatment with methylphenidate on expression of genes involved in neuronal plasticity, a differential effect of methylphenidate exposure in juveniles vs adults on expression of central neurotransmitter receptors and an effect of treatment in adolescence on survival of new brain cells.
Maltese: Ġiet sottomessa xi evidenza pre-klinika li tissuġġerixxi li hemm effett differenzjali ta' trattament akut meta mqabbel ma' trattament kroniku b'methylphenidate wara l-espressjoni tal-ġeni involuti filplastiċità newronali, effett differenzjali ta' espożizzjoni għal methylphenidate fiż-żgħażagħ meta mqabbel ma' dak fl-adulti wara l-espressjoni tar-reċetturi newrotrażmettituri u effett tat-trattament fladoloxxenza wara s-sopravvivenza taċ-ċelloli l-ġodda tal-moħħ.
English: Methylfenidaat HCl 5 mg tablets
Maltese: Methylfenidaat HCl 5 mg
English: Methylphenidate has been available in Europe for decades for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older.
Maltese: Methylphenidate ilha disponibbli fl-Ewropa għal deċennji għat-trattament tad-disturb tan-nuqqas ta' attenzjoni u ta' attività eċċessiva (ADHD) fi tfal li għandhom 6 snin u aktar.
English: Common: dizziness, dyskinesia, psychomotor hyperactivity, somnolence Uncommon: sedation, tremor
Maltese: Komuni: sturdament, diskinesija, iperattività psikomotorja, ħedla tan-ngħas Mhux komuni: sedazzjoni, rogħda
English: Methylphenidate did not affect reproductive performance or fertility at low multiples of the clinical dose.
Maltese: Methylphenidate ma affettwax il-ħila riproduttiva jew il-fertilità f'multipli baxxi tad-doża klinika.
English: Medice Arzneimittel Pütter GmbH & Co KG
Maltese: Medice Arzneimittel Pütter GmbH & Co
English: - The Committee considered the referral made under article 31 of Directive 2001/83/EC, as amended, for medicinal products containing methylphenidate initiated by the European Commission.
Maltese: - Il-Kumitat ikkunsidra r-riferiment magħmul skont l-Artikolu 31 tad-Direttiva 2001/83/KE, kif emendata, għall-prodotti mediċinali li fihom methylphenidate mibdi mill-Kummissjoni Ewropea.
English: • Glaucoma
Maltese: • Glawkoma
English: HOW TO <TAKE> <USE> methylphenidate
Maltese: Jekk tinsa <tieħu> <tuża> l-methylphenidate
English: Respiratory, thoracic and mediastinal disorders Common: cough, pharyngolaryngeal pain
Maltese: Disturbi respiratorji, toraċiċi u medjastiniċi Komuni: sogħla, uġigħ faringolarinġali
English: Very rare: cerebral arteritis and/or occlusion, peripheral coldness, Raynaud's phenomenon
Maltese: Rari ħafna: arterite u/jew okklużjoni ċerebrali, sensazzjoni ta' ksiħ f'livell periferiku, fenomenu ta' Raynaud
English: Uncommon: psychotic disorders*, auditory, visual, and tactile hallucinations*, anger, suicidal ideation*, mood altered, mood swings, restlessness, tearfulness, tics*, worsening of pre-existing tics or Tourette's syndrome*, hypervigilance, sleep disorder Rare: mania*, disorientation, libido disorder
Maltese: Mhux komuni: disturbi psikotiċi*, alluċinazzjonijiet viżivi, tas-smigħ u tal-mess*, rabja, formazzjoni ta' ideat suwiċidali*, altarazzjoni tal-burdata, tibdil fil-burdata, irrekwitezza, biki, attakki ta' skossi (tics)*, aggravar ta' attakki ta' skossi (tics) preeżistenti jew sindromu ta' Tourette*, iperviġilanza, disturb fl-irqad
English: Caution is recommended when administering methylphenidate with dopaminergic drugs, including antipsychotics.
Maltese: Attenzjoni hija rrakkomandata meta methylphenidate jingħata ma' mediċini dopaminerġiċi, inkluż antipsikotiċi.
English: Tabletss
Maltese: MG TABLETS
English: It is an amphetamine-like drug that has controlled drug status, which imposes restrictions on prescribing and handling.
Maltese: Hija mediċina li tixbah lamfetamina li għandha stejtus ta' mediċina kkontrollata, li timponi restrizzjonijiet fuq il-preskrizzjoni u l-immaniġġjar.
English: The use of methylphenidate is contraindicated in certain pre-existing cardiovascular disorders unless specialist paediatric cardiac advice has been obtained (see Section 4.3 ‘Contraindications').
Maltese: L-użu ta' methylphenidate huwa kontra-indikat f'ċertu disturbi kardjovaskulari eżistenti minn qabel sakemm ma jinkisibx parir kardijaku pedjatriku minn speċjalist (ara Sezzjoni 4.3).
English: Cardiovascular status
Maltese: Artralġja
English: NO Norway
Maltese: NO - InNorveġja
English: Ritalin LA 20 mg Hartkapseln mit veränderter Wirkstofffreisetzung
Maltese: Ritalin LA 20 mg Hartkapseln mit veränderter Wirkstofffreisetzung kapsuli iebsa b'rilaxx modifikat
English: MPH Novartis 20 mg Hartkapseln mit veränderter Wirkstofffreisetzung
Maltese: MPH Novartis 20 mg Hartkapseln mit veränderter Wirkstofffreisetzung kapsuli iebsa b'rilaxx modifikat
English: PL - Poland Medice Arzneimittel Pütter GmbH & Co. KG
Maltese: PL - Il-Polonja Medice Arzneimittel Pütter GmbH & Co.
English: 20 mg tablets
Maltese: 20 mg pilloli
English: Ritalin LA 40 mg Hartkapseln mit veränderter Wirkstofffreisetzung
Maltese: Ritalin LA 40 mg Hartkapseln mit veränderter Wirkstofffreisetzung kapsuli iebsa b'rilaxx modifikat
English: The reviews of the published literature and epidemiological data reached the same conclusion.
Maltese: Ir-reċensjonijiet tal-letteratura ippublikata u d-dejta epidemjoloġika waslu għall-istess konklużjoni.
English: MPH Novartis 40 mg Hartkapseln mit veränderter Wirkstofffreisetzung
Maltese: MPH Novartis 40 mg Hartkapseln mit veränderter Wirkstofffreisetzung kapsuli iebsa b'rilaxx modifikat
English: - The Committee, considered the benefit/risk balance of medicinal products containing methylphenidate in the treatment of ADHD in children aged 6 years and over and in adolescents in the EU.
Maltese: - Il-Kumitat ikkunsidra l-bilanċ tal-benefiċċju/riskju tal-prodotti mediċinali li fihom methylphenidate fit-trattament ta' ADHD fi tfal li għandhom 6 snin u aktar u f'adolexxenti flUE.
English: 10 mg tablets
Maltese: 10 mg pilloli
English: Methylphenidate can cause dizziness, drowsiness and visual disturbances including difficulties with accommodation, diplopia and blurred vision.
Maltese: Methylphenidate jista' jikkawża sturdament, ngħas u disturbi fil-vista inkluż diffikultajiet flakkomodazzjoni viżiva, vista doppja u vista mċajpra.